ARTBIO
Entity

  • ARTBIO

  • BETA

    Trend leader (A+)
    Existing signals make this entity one of the most dynamic startups

  • Social networks

    35 7,844

  • Activities

    deeptech biotech healthtech manufacturing

  • Entity types

    Startup

  • Location

    Cambridge, MA, USA

    Cambridge

    United States of America

  • Employees

    Scale: 51-200

    Estimated: 60

  • Engaged corporates

    0
    0 0

  • Added in Motherbase

    1 year, 6 months ago
Description
  • Value proposition

    Empowering patient-centric advances in cancer care

    ARTBIO is a clinical-stage radiopharmaceutical biotechnology company focused on developing a new class of alpha radioligand therapies (ART). Our unique patient-centric approach is underpinned by a deep understanding of cancer biology and the infrastructure needed to effectively design, manufacture, and distribute our therapies.

  • ARTBIO

    Learn about how ARTBIO is redefining cancer care through a new class of alpha radioligand therapies and building an ecosystem to maximize their potential.

    • https://artbio.com/
Corporate interactions BETA
Corporate TypeTweets Articles
No interactions
Similar entities
Last news
Show all articles
Social network dynamics